NovoCure(DE:038)
€10.34-0.76 (-12.93%)
DE:038
NovoCure financials statements
€10.34
At close:-0.76 (-12.93%)
NovoCure (038) Ratios
4 Followers
NovoCure Ratios
DE:038's free cash flow for Q3 2026 was $15.75M. For the 2026 fiscal year, DE:038's free cash flow was decreased by $-6.92M and operating cash flow was $22.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.90 | 1.46 | 5.78 | 7.00 | 7.53 |
| Quick Ratio | 2.71 | 1.42 | 5.56 | 6.82 | 7.36 |
| Cash Ratio | 0.46 | 0.22 | 1.34 | 0.73 | 1.47 |
| Solvency Ratio | -0.26 | -0.18 | -0.25 | -0.11 | -0.07 |
| Operating Cash Flow Ratio | -0.22 | -0.03 | -0.41 | 0.19 | 0.58 |
| Short-Term Operating Cash Flow Coverage | -4.21 | -0.05 | 0.00 | 0.00 | 12.38 |
| Net Current Asset Value | $ 182.87M | $ 225.97M | $ 250.78M | $ 361.05M | $ 344.52M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.36 | 0.55 | 0.52 | 0.49 | 0.51 |
| Debt-to-Equity Ratio | 0.85 | 1.90 | 1.64 | 1.32 | 1.42 |
| Debt-to-Capital Ratio | 0.46 | 0.65 | 0.62 | 0.57 | 0.59 |
| Long-Term Debt-to-Capital Ratio | 0.41 | 0.21 | 0.61 | 0.56 | 0.58 |
| Financial Leverage Ratio | 2.36 | 3.44 | 3.16 | 2.70 | 2.78 |
| Debt Service Coverage Ratio | -10.43 | -0.26 | -39.29 | -9.69 | -2.88 |
| Interest Coverage Ratio | 0.00 | -14.62 | -47.47 | -11.03 | -5.02 |
| Debt to Market Cap | 0.17 | 0.20 | 0.36 | 0.07 | 0.07 |
| Interest Debt Per Share | 2.60 | 6.45 | 5.65 | 5.66 | 5.71 |
| Net Debt to EBITDA | -1.53 | -4.74 | -2.00 | -6.91 | -9.70 |
| Profitability Margins | |||||
| Gross Profit Margin | 74.54% | 77.33% | 74.81% | 78.64% | 78.53% |
| EBIT Margin | -20.79% | -19.96% | -36.99% | -14.60% | -9.09% |
| EBITDA Margin | -18.55% | -18.11% | -34.84% | -12.62% | -7.17% |
| Operating Profit Margin | -23.47% | -28.17% | -45.72% | -16.64% | -8.29% |
| Pretax Profit Margin | -20.79% | -21.67% | -37.64% | -15.22% | -9.73% |
| Net Profit Margin | -20.79% | -27.86% | -40.65% | -17.20% | -10.91% |
| Continuous Operations Profit Margin | -20.79% | -27.86% | -40.65% | -17.20% | -10.91% |
| Net Income Per EBT | 99.98% | 128.56% | 107.98% | 113.06% | 112.05% |
| EBT Per EBIT | 88.59% | 76.93% | 82.34% | 91.42% | 117.46% |
| Return on Assets (ROA) | -16.94% | -13.59% | -18.06% | -7.77% | -5.12% |
| Return on Equity (ROE) | -40.01% | -46.82% | -57.12% | -20.97% | -14.21% |
| Return on Capital Employed (ROCE) | -26.47% | -35.20% | -24.08% | -8.67% | -4.45% |
| Return on Invested Capital (ROIC) | -25.94% | -16.23% | -24.08% | -8.67% | -4.42% |
| Return on Tangible Assets | -16.94% | -13.59% | -18.06% | -7.77% | -5.12% |
| Earnings Yield | -9.45% | -5.25% | -13.03% | -1.21% | -0.75% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.68 | 5.93 | 6.61 | 6.24 | 5.49 |
| Payables Turnover | 1.37 | 1.31 | 1.36 | 1.35 | 1.58 |
| Inventory Turnover | 4.06 | 3.91 | 3.36 | 3.91 | 4.70 |
| Fixed Asset Turnover | 4.46 | 5.06 | 5.21 | 7.80 | 9.93 |
| Asset Turnover | 0.81 | 0.49 | 0.44 | 0.45 | 0.47 |
| Working Capital Turnover Ratio | 1.69 | 1.00 | 0.56 | 0.57 | 0.59 |
| Cash Conversion Cycle | -113.18 | -124.69 | -104.76 | -118.84 | -86.61 |
| Days of Sales Outstanding | 64.24 | 61.56 | 55.26 | 58.54 | 66.45 |
| Days of Inventory Outstanding | 89.92 | 93.35 | 108.56 | 93.34 | 77.61 |
| Days of Payables Outstanding | 267.35 | 279.60 | 268.57 | 270.72 | 230.67 |
| Operating Cycle | 154.16 | 154.91 | 163.82 | 151.89 | 144.07 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.44 | -0.24 | -0.69 | 0.29 | 0.80 |
| Free Cash Flow Per Share | -0.68 | -0.64 | -0.94 | 0.09 | 0.57 |
| Dividend Paid and CapEx Coverage Ratio | -1.84 | -0.62 | -2.71 | 1.44 | 3.42 |
| Capital Expenditure Coverage Ratio | -1.84 | -0.62 | -2.71 | 1.44 | 3.42 |
| Operating Cash Flow Coverage Ratio | -0.17 | -0.04 | -0.12 | 0.05 | 0.14 |
| Operating Cash Flow to Sales Ratio | -0.07 | -0.04 | -0.14 | 0.06 | 0.15 |
| Free Cash Flow Yield | -5.25% | -2.15% | -6.32% | 0.12% | 0.75% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.60 | -19.10 | -7.67 | -82.96 | -133.09 |
| Price-to-Sales (P/S) Ratio | 2.20 | 5.31 | 3.12 | 14.27 | 14.51 |
| Price-to-Book (P/B) Ratio | 4.23 | 8.92 | 4.38 | 17.40 | 18.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -19.05 | -46.42 | -15.82 | 814.09 | 132.55 |
| Price-to-Operating Cash Flow Ratio | -29.40 | -121.86 | -21.66 | 249.35 | 93.84 |
| Price-to-Earnings Growth (PEG) Ratio | 0.49 | 0.96 | -0.06 | -1.45 | 0.35 |
| Enterprise Value Multiple | -13.39 | -34.07 | -10.95 | -119.99 | -212.02 |
| Enterprise Value | 1.63B | 3.73B | 1.94B | 8.15B | 8.14B |
| EV to EBITDA | -13.39 | -34.07 | -10.95 | -119.99 | -212.02 |
| EV to Sales | 2.48 | 6.17 | 3.82 | 15.15 | 15.21 |
| EV to Free Cash Flow | -21.51 | -53.93 | -19.36 | 863.82 | 138.91 |
| EV to Operating Cash Flow | -33.20 | -141.57 | -26.51 | 264.58 | 98.34 |
| Tangible Book Value Per Share | 3.05 | 3.34 | 3.41 | 4.22 | 3.97 |
| Shareholders’ Equity Per Share | 3.05 | 3.34 | 3.41 | 4.22 | 3.97 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.29 | -0.08 | -0.13 | -0.12 |
| Revenue Per Share | 5.88 | 5.61 | 4.79 | 5.14 | 5.17 |
| Net Income Per Share | -1.22 | -1.56 | -1.95 | -0.88 | -0.56 |
| Tax Burden | 1.00 | 1.29 | 1.08 | 1.13 | 1.12 |
| Interest Burden | 1.00 | 1.09 | 1.02 | 1.04 | 1.07 |
| Research & Development to Revenue | 0.34 | 0.35 | 0.44 | 0.38 | 0.38 |
| SG&A to Revenue | 0.64 | 0.71 | 0.32 | 0.25 | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 | 0.26 | 0.23 | 0.20 | 0.18 |
| Income Quality | 0.36 | 0.16 | 0.35 | -0.33 | -1.42 |
Currency in USD
